Literature DB >> 14614187

Brca2 (XRCC11) deficiency results in enhanced mutagenesis.

Maria Kraakman-van der Zwet1, Wouter W Wiegant, Małgorzata Z Zdzienicka.   

Abstract

Brca2 deficiency is associated with chromosomal instability and an increased risk of breast and other cancers. To examine the effect of Brca2 deficiency on mutagenesis, we measured the spontaneous mutation rate at the endogenous hprt gene in the Brca2-deficient Chinese hamster cell mutant V-C8. A 4.3-fold increase was found in the spontaneous mutation rate at this locus, indicating the importance of Brca2 in the prevention of mutagenesis. In addition, following exposure to IR, a 2.3-fold increase in mutant frequency per Gy was found for V-C8 in comparison with wild-type V79. These data suggest a potential risk from ionizing radiation for BRCA2 patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614187     DOI: 10.1093/mutage/geg032

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  7 in total

1.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

2.  Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.

Authors:  Caroline C Clark; Jeffrey N Weitzel; Timothy R O'Connor
Journal:  Mol Cancer Ther       Date:  2012-07-09       Impact factor: 6.261

3.  Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination.

Authors:  Atsushi Hatanaka; Mitsuyoshi Yamazoe; Julian E Sale; Minoru Takata; Kazuhiko Yamamoto; Hiroyuki Kitao; Eiichiro Sonoda; Koji Kikuchi; Yasukazu Yonetani; Shunichi Takeda
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.

Authors:  Natalia Issaeva; Huw D Thomas; Tatjana Djureinovic; Tatjana Djurenovic; Janneke E Jaspers; Ivaylo Stoimenov; Suzanne Kyle; Nicholas Pedley; Ponnari Gottipati; Rafal Zur; Kate Sleeth; Vicky Chatzakos; Evan A Mulligan; Cecilia Lundin; Evgenia Gubanova; Ariena Kersbergen; Adrian L Harris; Ricky A Sharma; Sven Rottenberg; Nicola J Curtin; Thomas Helleday
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

5.  Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.

Authors:  A Peasland; L-Z Wang; E Rowling; S Kyle; T Chen; A Hopkins; W A Cliby; J Sarkaria; G Beale; R J Edmondson; N J Curtin
Journal:  Br J Cancer       Date:  2011-07-05       Impact factor: 7.640

6.  Repression of mutagenesis by Rad51D-mediated homologous recombination.

Authors:  John M Hinz; Robert S Tebbs; Paul F Wilson; Peter B Nham; Edmund P Salazar; Hatsumi Nagasawa; Salustra S Urbin; Joel S Bedford; Larry H Thompson
Journal:  Nucleic Acids Res       Date:  2006-03-06       Impact factor: 16.971

7.  Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis.

Authors:  John M Hinz; Peter B Nham; Salustra S Urbin; Irene M Jones; Larry H Thompson
Journal:  Nucleic Acids Res       Date:  2007-05-21       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.